Clinical trial
Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally…
NCT00352105 · David Adelstein, Other · Completed
Key facts
| NCT number | NCT00352105 |
|---|---|
| Title | Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer |
| Official title | A Phase I/II Trial of Concurrent Chemotherapy and ZD1839 (IRESSA) With Hyperfractionated Radiation Therapy, Followed by Maintenance ZD1839 (IRESSA) for Patients With Locally Advanced Squamous Cell Head and Neck Cancer |
| Lead sponsor | David Adelstein, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, fluorouracil, Iressa, hyperfractionated radiation therapy |
| Enrollment | 60 |
| Start date | Apr 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | May 1, 2010 |
| First posted | Jul 14, 2006 |
| Last update posted | Nov 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: